Selected research
Industry Growth & Trends
Global Hydroxyprogesterone Caproate Industry Growth and Trends Forecast to 2032
Market perspective
The global Hydroxyprogesterone Caproate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hydroxyprogesterone Caproate include Zhejiang Xianju Pharmaceutical, Mylan Institutional, Upjohn Co, Symbiotec Pharmalab, Sun Pharmaceutical, Steroid Spa, Schering Ag, Naari Ag and Mcguff Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Hydroxyprogesterone Caproate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hydroxyprogesterone Caproate market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxyprogesterone Caproate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxyprogesterone Caproate.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hydroxyprogesterone Caproate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hydroxyprogesterone Caproate Market by Company
Zhejiang Xianju Pharmaceutical
Mylan Institutional
Upjohn Co
Symbiotec Pharmalab
Sun Pharmaceutical
Steroid Spa
Schering Ag
Naari Ag
Mcguff Pharmaceuticals Inc
Diosynth Bv
Aspen Oss B.V.
Antibioticos Spa
ANI Pharmaceuticals, Inc.
AMAG Pharmaceuticals
Hydroxyprogesterone Caproate Segment by Type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Hydroxyprogesterone Caproate Segment by Application
Hospitals Injection
Clinics Injection
Hydroxyprogesterone Caproate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hydroxyprogesterone Caproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1 mL Injection(Including 1.1 mL)
- 5 mL Injection
Applications
- Hospitals Injection
- Clinics Injection
Companies covered
- Zhejiang Xianju Pharmaceutical
- Mylan Institutional
- Upjohn Co
- Symbiotec Pharmalab
- Sun Pharmaceutical
- Steroid Spa
- Schering Ag
- Naari Ag
- Mcguff Pharmaceuticals Inc
- Diosynth Bv
- Aspen Oss B.V.
- Antibioticos Spa
- ANI Pharmaceuticals, Inc.
- AMAG Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hydroxyprogesterone Caproate Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hydroxyprogesterone Caproate Sales Estimates and Forecasts (2021-2032)
- 1.3 Hydroxyprogesterone Caproate Market by Type
- 1.3.1 1 mL Injection(Including 1.1 mL)
- 1.3.2 5 mL Injection
- 1.4 Global Hydroxyprogesterone Caproate Market Size by Type
- 1.4.1 Global Hydroxyprogesterone Caproate Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hydroxyprogesterone Caproate Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hydroxyprogesterone Caproate Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hydroxyprogesterone Caproate Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hydroxyprogesterone Caproate Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hydroxyprogesterone Caproate Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hydroxyprogesterone Caproate Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hydroxyprogesterone Caproate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hydroxyprogesterone Caproate Industry Trends
- 2.2 Hydroxyprogesterone Caproate Industry Drivers
- 2.3 Hydroxyprogesterone Caproate Industry Opportunities and Challenges
- 2.4 Hydroxyprogesterone Caproate Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hydroxyprogesterone Caproate Revenue (2021-2026)
- 3.2 Global Top Players by Hydroxyprogesterone Caproate Sales (2021-2026)
- 3.3 Global Top Players by Hydroxyprogesterone Caproate Price (2021-2026)
- 3.4 Global Hydroxyprogesterone Caproate Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hydroxyprogesterone Caproate Major Company Production Sites & Headquarters
- 3.6 Global Hydroxyprogesterone Caproate Company, Product Type & Application
- 3.7 Global Hydroxyprogesterone Caproate Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hydroxyprogesterone Caproate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hydroxyprogesterone Caproate Players Market Share by Revenue in 2025
- 3.8.3 2025 Hydroxyprogesterone Caproate Tier 1, Tier 2, and Tier 3
4 Hydroxyprogesterone Caproate Regional Status and Outlook
- 4.1 Global Hydroxyprogesterone Caproate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hydroxyprogesterone Caproate Historic Market Size by Region
- 4.2.1 Global Hydroxyprogesterone Caproate Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hydroxyprogesterone Caproate Sales in Value by Region (2021-2026)
- 4.2.3 Global Hydroxyprogesterone Caproate Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hydroxyprogesterone Caproate Forecasted Market Size by Region
- 4.3.1 Global Hydroxyprogesterone Caproate Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hydroxyprogesterone Caproate Sales in Value by Region (2027-2032)
- 4.3.3 Global Hydroxyprogesterone Caproate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxyprogesterone Caproate by Application
- 5.1 Hydroxyprogesterone Caproate Market by Application
- 5.1.1 Hospitals Injection
- 5.1.2 Clinics Injection
- 5.2 Global Hydroxyprogesterone Caproate Market Size by Application
- 5.2.1 Global Hydroxyprogesterone Caproate Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hydroxyprogesterone Caproate Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hydroxyprogesterone Caproate Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hydroxyprogesterone Caproate Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hydroxyprogesterone Caproate Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hydroxyprogesterone Caproate Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hydroxyprogesterone Caproate Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hydroxyprogesterone Caproate Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhejiang Xianju Pharmaceutical
- 6.1.1 Zhejiang Xianju Pharmaceutical Company Information
- 6.1.2 Zhejiang Xianju Pharmaceutical Business Overview
- 6.1.3 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
- 6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 6.2 Mylan Institutional
- 6.2.1 Mylan Institutional Company Information
- 6.2.2 Mylan Institutional Business Overview
- 6.2.3 Mylan Institutional Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Mylan Institutional Hydroxyprogesterone Caproate Product Portfolio
- 6.2.5 Mylan Institutional Recent Developments
- 6.3 Upjohn Co
- 6.3.1 Upjohn Co Company Information
- 6.3.2 Upjohn Co Business Overview
- 6.3.3 Upjohn Co Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Upjohn Co Hydroxyprogesterone Caproate Product Portfolio
- 6.3.5 Upjohn Co Recent Developments
- 6.4 Symbiotec Pharmalab
- 6.4.1 Symbiotec Pharmalab Company Information
- 6.4.2 Symbiotec Pharmalab Business Overview
- 6.4.3 Symbiotec Pharmalab Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Symbiotec Pharmalab Hydroxyprogesterone Caproate Product Portfolio
- 6.4.5 Symbiotec Pharmalab Recent Developments
- 6.5 Sun Pharmaceutical
- 6.5.1 Sun Pharmaceutical Company Information
- 6.5.2 Sun Pharmaceutical Business Overview
- 6.5.3 Sun Pharmaceutical Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sun Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
- 6.5.5 Sun Pharmaceutical Recent Developments
- 6.6 Steroid Spa
- 6.6.1 Steroid Spa Company Information
- 6.6.2 Steroid Spa Business Overview
- 6.6.3 Steroid Spa Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Steroid Spa Hydroxyprogesterone Caproate Product Portfolio
- 6.6.5 Steroid Spa Recent Developments
- 6.7 Schering Ag
- 6.7.1 Schering Ag Company Information
- 6.7.2 Schering Ag Business Overview
- 6.7.3 Schering Ag Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Schering Ag Hydroxyprogesterone Caproate Product Portfolio
- 6.7.5 Schering Ag Recent Developments
- 6.8 Naari Ag
- 6.8.1 Naari Ag Company Information
- 6.8.2 Naari Ag Business Overview
- 6.8.3 Naari Ag Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Naari Ag Hydroxyprogesterone Caproate Product Portfolio
- 6.8.5 Naari Ag Recent Developments
- 6.9 Mcguff Pharmaceuticals Inc
- 6.9.1 Mcguff Pharmaceuticals Inc Company Information
- 6.9.2 Mcguff Pharmaceuticals Inc Business Overview
- 6.9.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Product Portfolio
- 6.9.5 Mcguff Pharmaceuticals Inc Recent Developments
- 6.10 Diosynth Bv
- 6.10.1 Diosynth Bv Company Information
- 6.10.2 Diosynth Bv Business Overview
- 6.10.3 Diosynth Bv Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Diosynth Bv Hydroxyprogesterone Caproate Product Portfolio
- 6.10.5 Diosynth Bv Recent Developments
- 6.11 Aspen Oss B.V.
- 6.11.1 Aspen Oss B.V. Company Information
- 6.11.2 Aspen Oss B.V. Business Overview
- 6.11.3 Aspen Oss B.V. Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Aspen Oss B.V. Hydroxyprogesterone Caproate Product Portfolio
- 6.11.5 Aspen Oss B.V. Recent Developments
- 6.12 Antibioticos Spa
- 6.12.1 Antibioticos Spa Company Information
- 6.12.2 Antibioticos Spa Business Overview
- 6.12.3 Antibioticos Spa Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Antibioticos Spa Hydroxyprogesterone Caproate Product Portfolio
- 6.12.5 Antibioticos Spa Recent Developments
- 6.13 ANI Pharmaceuticals, Inc.
- 6.13.1 ANI Pharmaceuticals, Inc. Company Information
- 6.13.2 ANI Pharmaceuticals, Inc. Business Overview
- 6.13.3 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Product Portfolio
- 6.13.5 ANI Pharmaceuticals, Inc. Recent Developments
- 6.14 AMAG Pharmaceuticals
- 6.14.1 AMAG Pharmaceuticals Company Information
- 6.14.2 AMAG Pharmaceuticals Business Overview
- 6.14.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Product Portfolio
- 6.14.5 AMAG Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Hydroxyprogesterone Caproate Sales by Country
- 7.1.1 North America Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hydroxyprogesterone Caproate Sales by Country (2021-2026)
- 7.1.3 North America Hydroxyprogesterone Caproate Sales Forecast by Country (2027-2032)
- 7.2 North America Hydroxyprogesterone Caproate Market Size by Country
- 7.2.1 North America Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hydroxyprogesterone Caproate Market Size by Country (2021-2026)
- 7.2.3 North America Hydroxyprogesterone Caproate Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hydroxyprogesterone Caproate Sales by Country
- 8.1.1 Europe Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hydroxyprogesterone Caproate Sales by Country (2021-2026)
- 8.1.3 Europe Hydroxyprogesterone Caproate Sales Forecast by Country (2027-2032)
- 8.2 Europe Hydroxyprogesterone Caproate Market Size by Country
- 8.2.1 Europe Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hydroxyprogesterone Caproate Market Size by Country (2021-2026)
- 8.2.3 Europe Hydroxyprogesterone Caproate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hydroxyprogesterone Caproate Sales by Country
- 9.1.1 Asia-Pacific Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hydroxyprogesterone Caproate Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hydroxyprogesterone Caproate Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hydroxyprogesterone Caproate Market Size by Country
- 9.2.1 Asia-Pacific Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hydroxyprogesterone Caproate Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hydroxyprogesterone Caproate Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hydroxyprogesterone Caproate Sales by Country
- 10.1.1 South America Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hydroxyprogesterone Caproate Sales by Country (2021-2026)
- 10.1.3 South America Hydroxyprogesterone Caproate Sales Forecast by Country (2027-2032)
- 10.2 South America Hydroxyprogesterone Caproate Market Size by Country
- 10.2.1 South America Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hydroxyprogesterone Caproate Market Size by Country (2021-2026)
- 10.2.3 South America Hydroxyprogesterone Caproate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hydroxyprogesterone Caproate Sales by Country
- 11.1.1 Middle East and Africa Hydroxyprogesterone Caproate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hydroxyprogesterone Caproate Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hydroxyprogesterone Caproate Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hydroxyprogesterone Caproate Market Size by Country
- 11.2.1 Middle East and Africa Hydroxyprogesterone Caproate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hydroxyprogesterone Caproate Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hydroxyprogesterone Caproate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hydroxyprogesterone Caproate Value Chain Analysis
- 12.1.1 Hydroxyprogesterone Caproate Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hydroxyprogesterone Caproate Production Mode & Process
- 12.2 Hydroxyprogesterone Caproate Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hydroxyprogesterone Caproate Distributors
- 12.2.3 Hydroxyprogesterone Caproate Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst